Related Experiment Video
Updated: Sep 14, 2026

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus
Published on: December 5, 2015
[Hematologic diseases in pregnancy; a danger to mother and child or a calculable risk?]
A Panagiotopoulos1, K Goeschen, J Schneider
1Frauenklinik der Medizinischen Hochschule Hannover.
In 1985 the authors delivered six gravidae who had blood diseases during pregnancy; they included one patient with thalassemia minor, one with Hodgkin's disease, one with Glanzmann's thromboasthenia, one with Von Willebrand-Jürgens syndrome, one with Werlhof's disease and one with HELLP syndrome. The problems which arose were managed in close collaboration with internists and pediatricians and healthy infants were born in all cases. No aggravation of the basic disease was seen in any of the mothers. Cesarean section was necessary in two cases, while vaginal deliveries were accomplished in the other four. The chances of vaginal delivery were improved in particular by prior cervix priming with prostaglandin E2. In summary it may be said that with present-day monitoring and treatment possibilities, blood diseases during pregnancy have become a calculable risk. However, the cost--in terms both of equipment and personnel--must not be underestimated.
In 1985 the authors delivered six gravidae who had blood diseases during pregnancy; they included one patient with thalassemia minor, one with Hodgkin's disease, one with Glanzmann's thromboasthenia, one with Von Willebrand-Jürgens syndrome, one with Werlhof's disease and one with HELLP syndrome. The problems which arose were managed in close collaboration with internists and pediatricians and healthy infants were born in all cases. No aggravation of the basic disease was seen in any of the mothers. Cesarean section was necessary in two cases, while vaginal deliveries were accomplished in the other four. The chances of vaginal delivery were improved in particular by prior cervix priming with prostaglandin E2. In summary it may be said that with present-day monitoring and treatment possibilities, blood diseases during pregnancy have become a calculable risk. However, the cost--in terms both of equipment and personnel--must not be underestimated.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Teratogenicity
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Rh Blood Group
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Mitral Valve Prolapse III: Nursing Management

